Esperion Therapeutics, Inc.
Institutional Ownership & Holdings Analysis
About
esperion-therapeutics is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
# | Institution | Value |
---|---|---|
1 | BlackRock, Inc.(2025-03-31) | $20.9M |
2 | VANGUARD GROUP INC(2025-03-31) | $16.5M |
3 | WASATCH ADVISORS LP(2025-03-31) | $15.7M |
4 | Bellevue Group AG(2025-03-31) | $14.0M |
5 | Two Seas Capital LP(2025-03-31) | $10.0M |
6 | MORGAN STANLEY(2025-03-31) | $9.3M |
7 | Nuveen Asset Management, LLC(2024-12-31) | $6.9M |
8 | STATE STREET CORP(2025-03-31) | $6.5M |
9 | GEODE CAPITAL MANAGEMENT, LLC(2025-03-31) | $6.4M |
10 | MARSHALL WACE, LLP(2025-03-31) | $5.0M |
11 | Nuveen, LLC(2025-03-31) | $4.4M |
12 | Indaba Capital Management, L.P.(2025-03-31) | $4.3M |
13 | PenderFund Capital Management Ltd.(2025-03-31) | $4.1M |
14 | TWO SIGMA INVESTMENTS, LP(2025-03-31) | $3.9M |
15 | TWO SIGMA ADVISERS, LP(2025-03-31) | $3.6M |
16 | CITADEL ADVISORS LLC(2025-03-31) | $3.0M |
17 | CenterBook Partners LP(2024-12-31) | $2.9M |
18 | NORTHERN TRUST CORP(2025-03-31) | $2.2M |
19 | GOLDMAN SACHS GROUP INC(2025-03-31) | $2.2M |
20 | BANK OF AMERICA CORP /DE/(2025-03-31) | $2.2M |
As of 2025-03-31
Value:$20.9M
As of 2025-03-31
Value:$16.5M
As of 2025-03-31
Value:$15.7M
As of 2025-03-31
Value:$14.0M
As of 2025-03-31
Value:$10.0M
As of 2025-03-31
Value:$9.3M
As of 2024-12-31
Value:$6.9M
As of 2025-03-31
Value:$6.5M
As of 2025-03-31
Value:$6.4M
As of 2025-03-31
Value:$5.0M
#11Nuveen, LLC
As of 2025-03-31
Value:$4.4M
As of 2025-03-31
Value:$4.3M
As of 2025-03-31
Value:$4.1M
As of 2025-03-31
Value:$3.9M
As of 2025-03-31
Value:$3.6M
As of 2025-03-31
Value:$3.0M
As of 2024-12-31
Value:$2.9M
As of 2025-03-31
Value:$2.2M
As of 2025-03-31
Value:$2.2M
As of 2025-03-31
Value:$2.2M
Total Institutional Holders:219
Top 10 Holders Own:62.1%